Phase 3 Study of Dexpramipexole in ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Merit Cudkowicz, MD, MSc
Professor of Neurology of the Harvard Medical School
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Calvary Health Care Bethlehem
Melbourne, Victoria, Australia
- Az St-Lucas
Ghent, Belgium
- Uz Leuven
Leuven, Belgium
- Univ of Calgary / Foothills Mc
Calgary, Alberta, Canada
- Chum - Hopital Notre Dame
Montreal, Quebec, Canada
- Mcgill University
Montreal, Quebec, Canada
- London Health Sciences Centre
London, Canada
- Sunnybrook and Women'S College and Health Sciences Centre
Toronto, Canada
- University of British Columbia
Vancouver, Canada
- Chru de Lille - Hôpital Roger Salengro
Lille, France
- Chu de Limoges - Hôpital Dupuytren
Limoges, France
- Centre Hospitalier la Timone
Marseille, France
- Chu Gui de Chauliac
Montpellier, France
- Chu de Nice - Hôpital de L'Archet 1
Nice, France
- Hôpital la Pitié Salpétrière
Paris, France
- Charité - Universitätsmedizin Berlin
Berlin, Germany
- Bergmannsheil Gmbh
Bochum, Germany
- Medizinische Hochschule Hannover (mhh)
Hanover, Germany
- Universitätsklinikum Jena
Jena, Germany
- University of Ulm, Rku
Ulm, Germany
- Beaumont Hospital
Dublin, Ireland
- Academisch Medisch Centrum
Amsterdam, Netherlands
- Umc St. Radboud
Nijmegen, Netherlands
- Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
- Hospital Universitario de Bellvitge
Barcelona, Spain
- Hospital Vall D'Hebron
Barcelona, Spain
- Hospital Carlos Iii
Madrid, Spain
- Hospital la Paz
Madrid, Spain
- Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden
- Karolinska Universitetssjukhuset, Solna
Stockholm, Sweden
- Queen Elizabeth Hospital
Birmingham, United Kingdom
- Walton Centre for Neurology & Neurosurgery
Liverpool, United Kingdom
- Kings College Hospital Nhs Foundation Trust
London, United Kingdom
- Newcastle University Hospital - Clinical Ageing Research Unit
Newcastle, United Kingdom
- John Radcliffe Hospital
Oxford, United Kingdom
- Sheffield Institute for Transnational Neuroscience
Sheffield, United Kingdom
- Barrow Neurological Institute - St. Joseph'S Hospital
Phoenix, Arizona, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 30 Nov 2012
- Completion
- 30 Nov 2012
- Last update posted
- 7 Jun 2021
- Registered enrollment
- 942
- Registry id
- NCT01281189
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.